By Priyanjana Pramanik, MSc. Researchers reveal why lung cancer in people who never smoked is increasing and explore how ...

Background and objectives Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.

April marks National Cancer Prevention and Early Detection Month, and the American Lung Association is kicking it off by offering free lung cancer screenings to District residents in Southeast ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

About a decade later, the U.S. Preventive Services Taskforce (USPSTF) issued updated guidelines recommending annual screening for lung cancer with low-dose CT for adults ages 50 to 80 years with a 20 ...

The Essentia Health-Duluth Clinic is improving lung cancer detection through a new cutting-edge robot system and the expansion of a specialty clinic dedicated to early lung cancer detection and ...

GREENVILLE, S.C. (FOX Carolina) - Lung cancer is the deadliest cancer in the U.S., killing around 130,000 people every year. Doctors say one of the reasons it’s so deadly is because it’s often caught ...

JUPITER, Fla. — Although Lung Cancer Awareness Month is observed nationally in November, a woman who attended a Let’s Hear It meet-up said she would like to see awareness raised year-round. WPTV ...

Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer cases more quickly. The U.S. tech giant will provide its suite of artificial-intelligence-powered radiology ...

A state-led AI screening drive flags hidden tumours early and sparks national scale-up talks ...

Jan 20 (Reuters) - Bristol Myers Squibb ‌said on Tuesday it had ‌signed an agreement with Microsoft to use the tech company's AI-enabled radiology platform to help speed up early ‍detection of lung ...

We studied a total of 2,287 participants (1,197 male, 1,090 female). More female participants developed NSCLC during the follow-up period (4.4% v 2.5%, P = .015). The only risk factor of NSCLC ...